A potential breakthrough in cardiovascular medicine has emerged with the development of lepodisiran, an experimental drug by pharmaceutical company Eli Lilly. The drug has demonstrated an ...

The drug, made by Eli Lilly and called lepodisiran, lowered levels of a tiny particle called Lp(a) by 94% with a single shot, the study shows. Lp(a) is a mix of protein and lipids. The drug's ...

The drug, made by Eli Lilly and called lepodisiran, lowered levels of a tiny particle called Lp(a) by 94% with a single shot, the study shows. Lp(a) is a mix of protein and lipids. The drug's effects ...

Max, formerly known as HBO Max, officially has a new logo on Sunday night, March 30. The new logo for Warner Bros. Discovery's steaming platform was unveiled on Sunday evening. The new logo gives ...

Experimental Lilly Drug Cuts Genetic Heart Disease Risk Factor by 94% in Trial By Julie Steenhuysen CHICAGO (Reuters) - The highest dose of an experimental drug developed by Eli Lilly ...

CHICAGO, March 30 (Reuters) - The highest dose of an experimental drug developed by Eli Lilly (LLY.N), opens new tab significantly reduced levels of a genetically inherited risk factor for heart ...

CHICAGO (Reuters) - The highest dose of an experimental drug developed by Eli Lilly significantly reduced levels of a genetically inherited risk factor for heart disease in a midstage trial ...

CHICAGO (Reuters) - The highest dose of an experimental drug developed by Eli Lilly significantly reduced levels of a genetically inherited risk factor for heart disease in a midstage trial, according ...

EU rejection based on risk of serious brain swelling Lilly seeks re-examination of EU decision on Kisunla CHMP previously rejected Leqembi before recommending approval March 28 (Reuters ...